SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-011805
Filing Date
2023-04-11
Accepted
2023-04-11 09:15:40
Documents
17
Period of Report
2023-04-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40229
2 ex99-1.htm EX-99.1 3556
3 ex99-1_001.jpg GRAPHIC 218760
4 ex99-1_002.jpg GRAPHIC 216262
5 ex99-1_003.jpg GRAPHIC 214379
6 ex99-1_004.jpg GRAPHIC 216510
  Complete submission text file 0001493152-23-011805.txt   1412526

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE aneb-20230411.xsd EX-101.SCH 3224
8 XBRL LABEL FILE aneb-20230411_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE aneb-20230411_pre.xml EX-101.PRE 22357
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3734
Mailing Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40388 | Film No.: 23812486
SIC: 2834 Pharmaceutical Preparations